First Time Loading...

Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 79.48 USD 0.37% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. [ Read More ]

The intrinsic value of one MDT stock under the Base Case scenario is 93.22 USD. Compared to the current market price of 79.48 USD, Medtronic PLC is Undervalued by 15%.

Key Points:
MDT Intrinsic Value
Base Case
93.22 USD
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medtronic PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MDT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medtronic PLC

Provide an overview of the primary business activities
of Medtronic PLC.

What unique competitive advantages
does Medtronic PLC hold over its rivals?

What risks and challenges
does Medtronic PLC face in the near future?

Has there been any significant insider trading activity
in Medtronic PLC recently?

Summarize the latest earnings call
of Medtronic PLC.

What significant events have occurred
in Medtronic PLC over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medtronic PLC.

Provide P/S
for Medtronic PLC.

Provide P/E
for Medtronic PLC.

Provide P/OCF
for Medtronic PLC.

Provide P/FCFE
for Medtronic PLC.

Provide P/B
for Medtronic PLC.

Provide EV/S
for Medtronic PLC.

Provide EV/GP
for Medtronic PLC.

Provide EV/EBITDA
for Medtronic PLC.

Provide EV/EBIT
for Medtronic PLC.

Provide EV/OCF
for Medtronic PLC.

Provide EV/FCFF
for Medtronic PLC.

Provide EV/IC
for Medtronic PLC.

Show me price targets
for Medtronic PLC made by professional analysts.

What are the Revenue projections
for Medtronic PLC?

How accurate were the past Revenue estimates
for Medtronic PLC?

What are the Net Income projections
for Medtronic PLC?

How accurate were the past Net Income estimates
for Medtronic PLC?

What are the EPS projections
for Medtronic PLC?

How accurate were the past EPS estimates
for Medtronic PLC?

What are the EBIT projections
for Medtronic PLC?

How accurate were the past EBIT estimates
for Medtronic PLC?

Compare the revenue forecasts
for Medtronic PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medtronic PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medtronic PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medtronic PLC compared to its peers.

Compare the P/E ratios
of Medtronic PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Medtronic PLC with its peers.

Analyze the financial leverage
of Medtronic PLC compared to its main competitors.

Show all profitability ratios
for Medtronic PLC.

Provide ROE
for Medtronic PLC.

Provide ROA
for Medtronic PLC.

Provide ROIC
for Medtronic PLC.

Provide ROCE
for Medtronic PLC.

Provide Gross Margin
for Medtronic PLC.

Provide Operating Margin
for Medtronic PLC.

Provide Net Margin
for Medtronic PLC.

Provide FCF Margin
for Medtronic PLC.

Show all solvency ratios
for Medtronic PLC.

Provide D/E Ratio
for Medtronic PLC.

Provide D/A Ratio
for Medtronic PLC.

Provide Interest Coverage Ratio
for Medtronic PLC.

Provide Altman Z-Score Ratio
for Medtronic PLC.

Provide Quick Ratio
for Medtronic PLC.

Provide Current Ratio
for Medtronic PLC.

Provide Cash Ratio
for Medtronic PLC.

What is the historical Revenue growth
over the last 5 years for Medtronic PLC?

What is the historical Net Income growth
over the last 5 years for Medtronic PLC?

What is the current Free Cash Flow
of Medtronic PLC?

Financials

Balance Sheet Decomposition
Medtronic PLC

Current Assets 22.5B
Cash & Short-Term Investments 8.3B
Receivables 6B
Other Current Assets 8.2B
Non-Current Assets 68.3B
Long-Term Investments 1.6B
PP&E 5.8B
Intangibles 54.9B
Other Non-Current Assets 6B
Current Liabilities 9.8B
Accounts Payable 2B
Accrued Liabilities 5.3B
Short-Term Debt 1B
Other Current Liabilities 1.5B
Non-Current Liabilities 29.3B
Long-Term Debt 24.2B
Other Non-Current Liabilities 5.1B
Efficiency

Earnings Waterfall
Medtronic PLC

Revenue
32.3B USD
Cost of Revenue
-11.1B USD
Gross Profit
21.2B USD
Operating Expenses
-14.8B USD
Operating Income
6.4B USD
Other Expenses
-2.2B USD
Net Income
4.2B USD

Free Cash Flow Analysis
Medtronic PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

MDT Profitability Score
Profitability Due Diligence

Medtronic PLC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
57/100
Profitability
Score

Medtronic PLC's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

MDT Solvency Score
Solvency Due Diligence

Medtronic PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
54/100
Solvency
Score

Medtronic PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDT Price Targets Summary
Medtronic PLC

Wall Street analysts forecast MDT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDT is 95.99 USD with a low forecast of 75.75 USD and a high forecast of 109.2 USD.

Lowest
Price Target
75.75 USD
5% Downside
Average
Price Target
95.99 USD
21% Upside
Highest
Price Target
109.2 USD
37% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

MDT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

MDT Price
Medtronic PLC

1M 1M
-5%
6M 6M
+9%
1Y 1Y
-5%
3Y 3Y
-35%
5Y 5Y
+4%
10Y 10Y
+65%
Annual Price Range
79.48
52w Low
69.43
52w High
91.38
Price Metrics
Average Annual Return 2.84%
Standard Deviation of Annual Returns 26.21%
Max Drawdown -46%
Shares Statistics
Market Capitalization 105.7B USD
Shares Outstanding 1 327 820 032
Percentage of Shares Shorted 0.94%

MDT Return Decomposition
Main factors of price return

What is price return decomposition?

MDT News

Other Videos

Last Important Events
Medtronic PLC

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Medtronic PLC

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Medtronic PLC Logo
Medtronic PLC

Country

Ireland

Industry

Health Care

Market Cap

105.7B USD

Dividend Yield

3.48%

Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The company is headquartered in Dublin, Dublin and currently employs 90,000 full-time employees. The firm develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients. The firm has four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Medical Surgical Portfolio, the Neuroscience Portfolio, and the Diabetes Operating Unit. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions.

Contact

DUBLIN
DUBLIN
20 On Hatch, Hatch Street Lower
+1135314381700.0
http://www.medtronic.com/

IPO

1977-11-21

Employees

90 000

Officers

Chairman of the Board & CEO
Mr. Geoffrey Straub Martha
Executive VP & CFO
Ms. Karen L. Parkhill
Executive VP & President of Cardiovascular Portfolio
Mr. Sean M. Salmon
Executive VP & President of Global Regions
Mr. Robert J. W. ten Hoedt
Senior Vice President of Global Operations and Business Services
Mr. Mark Ploof
Senior VP, Global Controller & Chief Accounting Officer
Ms. Jennifer M. Kirk
Show More
Senior VP and Chief Technology & Innovation Officer
Dr. Kenneth E. Washington Ph.D.
Senior VP and Chief Scientific, Medical & Regulatory Officer
Dr. Laura Mauri M.D., M.Sc.
VP & Head of Investor Relations
Mr. Ryan Weispfenning
Executive VP, General Counsel & Secretary
Mr. Ivan K. Fong
Show Less

See Also

Discover More
What is the Intrinsic Value of one MDT stock?

The intrinsic value of one MDT stock under the Base Case scenario is 93.22 USD.

Is MDT stock undervalued or overvalued?

Compared to the current market price of 79.48 USD, Medtronic PLC is Undervalued by 15%.